
    
      Note regarding the primary purpose of the study: In the Study Design section, this protocol
      is classified as "Other", since it is specifically designed to examine the effect of
      telmisartan administered in conjunction with ART on the size of HIV reservoirs in the central
      nervous system.
    
  